The search for life on Earth is speeding up, not slowing down. Scientists are now identifying more than 16,000 new species ...
In connection with the Company’s prior financing in October 2025, 2,722,642 Class A ordinary shares were issued, with one Class A warrant and one Class B warrant issued for each such Class A ordinary ...
Available for 1x1 meetings: December 11, between 2:00-5:00pm ET, December 15 between 10:00-3:00pm ET and December 16 between 10:00-5:00pm ET. Schedule 1x1 Meetings here This will be a live, ...
MONTREAL, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Defence Therapeutics (OTCQB: DTCFF), based in adMare BioInnovations Technoparc, Montreal, focused on advancing a proprietary intracellular delivery platform ...
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an ...
Manipur, has announced the 2026 board examination schedule for Class 11 and 12. Class 12 practical exams commence January ...
Students in Manipur preparing for the Class 11 and 12 board examinations can now plan their academic calendar with greater clarity, as the Council of Higher Secondary Education Manipur (COHSEM) has ...
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend live presentations, or schedule ...
SAN DIEGO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) (“Thiogenesis” or the “Company”), a clinical-stage biotechnology company developing ...
NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, announced the agenda for the Life Sciences Virtual Investor Forum to be ...
SYDNEY, Dec. 08, 2025 (GLOBE NEWSWIRE) — AI and Medical Technology company Echo IQ (“the Company” or “Echo IQ”) (ASX: EIQ) today announced that Dustin Haines, Chief Executive Officer, will present ...